However, it has been reported in leukemia that the lack of expression of NKG2D ligands in tumor cells could serve as an immunoevasive mechanism and even as a leukemia CSC marker, as NKG2D− cells showed a more stem-like phenotype, including enhanced chemoresistance [84]. Here, KLRK1 is linked to leukemia.